The Fanconi anaemia/BRCA pathway

Cited by (823)

Items 301–400 of 823

1. ASCIZ regulates lesion‐specific Rad51 focus formation and apoptosis after methylating DNA damage
   Carolyn J. McNees, Lindus A. Conlan, Nora Tenis, Jörg Heierhorst · 2005 · The EMBO Journal
2. Aging, hematopoiesis, and the myelodysplastic syndromes
   Stephen S. Chung, Christopher Y. Park · 2017 · Blood Advances
3. Metformin inhibits stromal aromatase expression and tumor progression in a rodent model of postmenopausal breast cancer
   Erin Danielle Giles, Sonali Jindal, Elizabeth A. Wellberg, Troy Schedin, Steven M. Anderson, Ann D. Thor, Dean P. Edwards, Paul S. MacLean, Pepper S. Schedin · 2018 · Breast Cancer Research
4. Efficient DNA interstrand crosslinking by 6-thioguanine and UVA radiation
   Brem, Reto, Daehn, Ilse, Karran, Peter · 2011 · DNA Repair
5. Transcriptional Down-Regulation of Brca1 and E-cadherin by CtBP1 in Breast Cancer
   Yu Deng, Hui Deng, Jing Liu, G. Han, S. Malkoski, Bo-Lin Liu, Rui Zhao, Xiao-Jing Wang, Qinghong Zhang · 2011 · Molecular Carcinogenesis
6. BRCA 1/2-Mutation Related and Sporadic Breast and Ovarian Cancers: More Alike than Different
   Melissa Amber Burgess, Shannon Puhalla · 2014 · Frontiers in Oncology
7. Regulation of Rad51 Recombinase Presynaptic Filament Assembly via Interactions with the Rad52 Mediator and the Srs2 Anti-recombinase
   Changhyun Seong, Sierra A. Colavito, Youngho Kwon, Patrick Sung, Lumír Krejčí · 2009 · Journal of Biological Chemistry
8. Fanconi anemia proteins and endogenous stresses
   Qishen Pang, Paul R. Andreassen · 2009 · Mutation research. Fundamental and molecular mechanisms of mutagenesis
9. Early Events in the DNA Damage Response
   Irene M. Ward, Junjie Chen · 2004 · Current topics in developmental biology/Current Topics in Developmental Biology
10. Fanconi Anemia Proteins, DNA Interstrand Crosslink Repair Pathways, and Cancer Therapy
    Paul R. Andreassen, Keqin Ren · 2009 · Current Cancer Drug Targets
11. Fanconi anemia C gene product regulates expression of genes involved in differentiation and inflammation
    Romina Zanier, Delphine Briot, Jean-Antoine Dugas du Villard, Alain R. Sarasin, Filippo Rosselli · 2004 · Oncogene
12. Function and Malfunction of Hematopoietic Stem Cells in Primary Bone Marrow Failure Syndromes
    Antonio Maria Risitano, Jaroslaw Pawel Maciejewski, Carmine Selleri, Bruno Rotoli, Antonio Maria Risitano, Jaroslaw Pawel Maciejewski · 2007 · Current Stem Cell Research & Therapy
13. The zebrafish kidney mutant zeppelin reveals that brca2/fancd1 is essential for pronephros development
    Paul Kroeger, Bridgette E. Drummond, Rachel Miceli, Michael McKernan, Gary F. Gerlach, Amanda N. Marra, Annemarie Fox, Kristen K. McCampbell, Ignaty Leshchiner, Adriana Rodríguez‐Marí et al. · 2017 · Developmental Biology
14. Delayed diagnosis and complications of Fanconi anaemia at advanced age – a paradigm
    Kirsten Huck, Helmut Hanenberg, Sonja Gudowius, Roland R. Fenk, Reinhard Kalb, Kornelia Neveling, Beate Betz, Dieter Niederacher, Rainer R. Haas, Ulrich Göbel et al. · 2006 · British Journal of Haematology
15. The Fanconi anemia pathway limits the severity of mutagenesis
    John M. Hinz, Peter B. Nham, Edmund P. Salazar, Larry H. Thompson · 2006 · DNA repair
16. Chromosomal instability
    Susanne M. Gollin · 2003 · Current Opinion in Oncology
17. Stem Cell Gene Therapy for Fanconi Anemia: Report from the 1st International Fanconi Anemia Gene Therapy Working Group Meeting
    Jakub Tolar, Jennifer E. Adair, Michael Nicolas Antoniou, Cynthia C. Bartholomae, Pamela Sue Becker, Bruce R. Blazar, Juan Antonio Bueren, Thomas Carroll, Marina Cavazzana, D. Wade Clapp et al. · 2011 · Molecular Therapy
18. Alterations in P-Glycoprotein Expression and Function Between Macrophage Subsets
    Theodore James Cory, Hui He, Lee C. Winchester, Santosh Kumar, Courtney Vail Fletcher · 2016 · Pharmaceutical Research
19. Acquired resistance of pancreatic cancer cells to cisplatin is multifactorial with cell context-dependent involvement of resistance genes
    Roman Mezencev, Lilya V. Matyunina, G T Wagner, John F. McDonald · 2016 · Cancer Gene Therapy
20. CCAAT/enhancer binding protein delta (C/EBPδ, CEBPD)-mediated nuclear import of FANCD2 by IPO4 augments cellular response to DNA damage
    Jun Wang, Tapasree Roy Sarkar, Ming Zhou, Shikha Sharan, Daniel A. Ritt, Timothy D. Veenstra, Deborah K. Morrison, A‐Mei Huang, Esta Sterneck · 2010 · Proceedings of the National Academy of Sciences
21. Redox-dependent Brca1 transcriptional regulation by an NADH-sensor CtBP1
    Yu Deng, J Liu, Gangwen Han, Shi-Long Lu, S-Y Wang, Stephen P. Malkoski, Aik Choon Tan, Chu‐Xia Deng, X-J Wang, Qinghong Zhang · 2010 · Oncogene
22. FANCD2 associated with sporadic breast cancer risk
    Eva Barroso · 2006 · Carcinogenesis
23. Association of FANCC and PTCH1 with the Development of Early Dysplastic Lesions of the Head and Neck
    Amlan Ghosh, Susmita Ghosh, Guru Prasad Maiti, Sudeshna Mukherjee, Nupur Mukherjee, Jayanta Chakraborty, Anup Kumar Roy, Susanta Roychoudhury, Chinmay Kumar Panda · 2011 · Annals of Surgical Oncology
24. New Targeted Agents in Gynecologic Cancers: Synthetic Lethality, Homologous Recombination Deficiency, and PARP Inhibitors
    Fong W. Liu, Krishnansu S. Tewari · 2016 · Current Treatment Options in Oncology
25. BRCA2 Regulates Homologous Recombination in Response to DNA Damage: Implications for Genome Stability and Carcinogenesis
    Christine Abaji, Isabelle Cousineau, Abdellah Belmaaza · 2005 · Cancer Research
26. Mechanism of RecA‐mediated homologous recombination revisited by single molecule nanomanipulation
    Renaud Fulconis, Judith Miné-Hattab, Aurélien Bancaud, Marie Dutreix, Jean‐Louis Viovy · 2006 · The EMBO Journal
27. Enhanced TNF-α–induced apoptosis in Fanconi anemia type C–deficient cells is dependent on apoptosis signal-regulating kinase 1
    Khadijeh Bijangi‐Vishehsaraei, Mohammad Reza Saadatzadeh, Adam Werne, Kristina A. Wilson McKenzie, Reuben Kapur, Hidenori Ichijo, Laura S. Haneline · 2005 · Blood
28. Pir51, a Rad51-interacting protein with high expression in aggressive lymphoma, controls mitomycin C sensitivity and prevents chromosomal breaks
    Sarah E. Henson, Shih-Chang Tsai, Cindy Sue Malone, Shahe V. Soghomonian, Yan Ouyang, Randolph Wall, York Marahrens, Michael A. Teitell · 2006 · Mutation research. Fundamental and molecular mechanisms of mutagenesis
29. Expression analysis of candidate breast tumour suppressor genes on chromosome 16q
    Tom van Wezel, Marcel Lombaerts, Eddy H.J. Van Roon, Katja Philippo, Hans J. Baelde, Károly Szuhai, Cees J. Cornelisse, Anne‐Marie Cleton-Jansen · 2005 · Breast Cancer Research
30. Expression of the BRCA1-interacting protein Brip1/BACH1/FANCJ is driven by E2F and correlates with human breast cancer malignancy
    Eelen, G, Vanden Bempt, I, Verlinden, L, Drijkoningen, M, Smeets, A, Neven, P, Christiaens, M R, Marchal, K, Bouillon, R, Verstuyf, A · 2008 · Oncogene
31. Activation of the Fanconi Anemia/BRCA Pathway and Recombination Repair in the Cellular Response to Solar Ultraviolet Light
    Dunn, Jessica, Potter, Marisa, Rees, Adam, Rünger, Thomas M. · 2006 · Cancer Research
32. The Fanconi Anemia Protein FANCM Is Controlled by FANCD2 and the ATR/ATM Pathways
    Alexandra Sobeck, Stacie Stone, Igor Landais, Bendert de Graaf, Maureen E. Hoatlin · 2009 · Journal of Biological Chemistry
33. The Fanconi anemia pathway and DNA interstrand cross-link repair
    Xiaoyu Su, Jun Huang · 2011 · Protein & Cell
34. Knockdown of αII spectrin in normal human cells by siRNA leads to chromosomal instability and decreased DNA interstrand cross-link repair
    Laura McMahon, Pan Zhang, Deepa Sridharan, Joel A. Lefferts, Muriel Wikswo Lambert · 2009 · Biochemical and Biophysical Research Communications
35. Drosophila homologs of FANCD2 and FANCL function in DNA repair
    Lorri R. Marek, Allen E. Bale · 2006 · DNA repair
36. p53, BRCA1 and Breast Cancer Chemoresistance
    Kimberly A. Scata, Wafik S. El‐Deiry · 2007 · Advances in experimental medicine and biology
37. Functional Interplay between BRCA2/FancD1 and FancC in DNA Repair
    Hiroyuki Kitao, Kazuhiko Yamamoto, Nobuko Matsushita, Mioko Ohzeki, Masamichi Ishiai, Minoru Takata · 2006 · Journal of Biological Chemistry
38. RIF1: A novel regulatory factor for DNA replication and DNA damage response signaling
    Ramesh Kumar, Chit Fang Cheok · 2014 · DNA repair
39. Mutator Phenotype ofCaenorhabditis elegansDNA Damage Checkpoint Mutants
    Jasper Harris, Mia Rochelle Lowden, Iuval Clejan, Monika Tzoneva, James H. Thomas, Jonathan Hodgkin, Shawn Cameron Ahmed · 2006 · Genetics
40. DNA Repair Biomarkers Predict Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer
    Brian Michael Alexander, Xiao Zhe Wang, Andrzej Niemierko, David T. Weaver, Raymond H. Mak, Kevin S. Roof, Panagiotis M. Fidias, John R. Wain, Noah C. Choi · 2011 · International Journal of Radiation Oncology*Biology*Physics
41. Genomic instability drives tumorigenesis and metastasis and its implications for cancer therapy
    Shihui Guo, Xiao Ming Zhu, Ziyuan Huang, Chuzhong Wei, Jiaao Yu, Lin Zhang, Jinghua Feng, Mingdong Li, Zesong Li · 2022 · Biomedicine & Pharmacotherapy
42. Identification and characterization of novel mutations of the major Fanconi anemia gene FANCA in the Japanese population
    Hiroshi Yagasaki, Satoshi Hamanoue, Tsukasa Oda, Tatsutoshi Nakahata, Shigetaka Asano, Takayuki Yamashita · 2004 · Human Mutation
43. Nijmegen breakage syndrome diagnosed as Fanconi anaemia
    Helen V. New, Catherine M. Cale, Marc D. Tischkowitz, Alison Jones, Paul T. Telfer, Paul A. Veys, Alan D. D’Andrea, Christopher George Mathew, Ian M Hann · 2004 · Pediatric Blood & Cancer
44. Checkpoint Mediators: Relaying Signals from DNA Strand Breaks
    Christine E. Canman · 2003 · Current Biology
45. Tip60 Is Required for DNA Interstrand Cross-link Repair in the Fanconi Anemia Pathway
    James Hejna, Megan L. Holtorf, Jennie Hines, L. Mathewson, Aaron Hemphill, Muhsen Al-Dhalimy, Susan B. Olson, Robb E. Moses · 2008 · Journal of Biological Chemistry
46. Role of chromosomal aberrations in clonal diversity and progression of acute myeloid leukemia
    Tilmann Bochtler, Stefan Fröhling, A. Krämer · 2015 · Leukemia
47. Genetic polymorphisms in 85 DNA repair genes and bladder cancer risk
    Stefan Michiels, Agnès Laplanche, Thomas Boulet, Philippe Dessen, Bertrand D. Guillonneau, A. Méjean, François Desgrandchamps, Mark G. Lathrop, Alain R. Sarasin, Simone Benhamou · 2009 · Carcinogenesis
48. FAVL elevation in human tumors disrupts Fanconi anemia pathway signaling and promotes genomic instability and tumor growth
    Jun Zhang, Deping Zhao, Hwan Ki Park, Hong Wang, Roy B. Dyer, Wanguo Liu, George G. Klee, Mark A. McNiven, Donald J. Tindall, Julian R. Molina et al. · 2010 · Journal of Clinical Investigation
49. Fancd2 in vivo interaction network reveals a non-canonical role in mitochondrial function
    Tingting Zhang, Wei Du, Andrew F. Wilson, Satoshi H. Namekawa, Paul R. Andreassen, Amom Ruhikanta Meetei, Qishen Pang · 2017 · Scientific Reports
50. Gene expression profiling of homologous recombination repair pathway indicates susceptibility for olaparib treatment in malignant pleural mesothelioma in vitro
    Sabrina Borchert, Michael Wessolly, Jan Schmeller, Elena Mairinger, Jens Kollmeier, Thomas Hager, Thomas Mairinger, Thomas Herold, Daniel Christian Christoph, Robert F. H. Walter et al. · 2019 · BMC Cancer
51. G1 and S-Phase Checkpoints, Chromosome Instability, and Cancer
    Hiroshi Nojima · 2004 · Humana Press eBooks
52. Hypoxia disrupts the Fanconi anemia pathway and sensitizes cells to chemotherapy through regulation of UBE2T
    Chantal H.M.A. Ramaekers, Twan van den Beucken, Alice X. Meng, Shaqil Nadirali Kassam, John Thoms, Robert Glen Bristow, Bradly G. Wouters · 2011 · Radiotherapy and Oncology
53. Targeting Fanconi Anemia/BRCA2 Pathway Defects in Cancer: The Significance of Preclinical Pharmacogenomic Models
    Eike Gallmeier, Scott E. Kern · 2007 · Clinical Cancer Research
54. Assessing the Link between BACH1 and BRCA1 in the FA Pathway
    Sharon B. Cantor, Paul R. Andreassen · 2005 · Cell Cycle
55. A Genomic Instability Score in Discriminating Nonequivalent Outcomes of BRCA1/2 Mutations and in Predicting Outcomes of Ovarian Cancer Treated with Platinum-Based Chemotherapy
    Shaojun Zhang, Yuan Yuan, Dapeng Hao · 2014 · PLoS ONE
56. Amelioration of Radiation-Induced Oral Cavity Mucositis and Distant Bone Marrow Suppression in Fanconi Anemia Fancd2–/– (FVB/N) Mice by Intraoral GS-Nitroxide JP4-039
    Hebist Berhane, Ashwin Shinde, Ronny Kalash, Karen L. Xu, Michael W. Epperly, Julie P. Goff, Darcy Franicola, Xichen Zhang, Tracy M. Dixon, Donna S. Shields et al. · 2014 · Radiation Research
57. Reversal of multidrug resistance by curcumin through FA/BRCA pathway in multiple myeloma cell line MOLP-2/R
    Hui Xiao, Qi Xiao, Kejian Zhang, Xuelan Zuo, Umid Kumar Shrestha · 2009 · Annals of Hematology
58. C. elegans: A model of Fanconi anemia and ICL repair
    Jillian L. Youds, Louise J. Barber, Simon J. Boulton · 2008 · Mutation research. Fundamental and molecular mechanisms of mutagenesis
59. Age-dependent accumulation of recombinant cells in the mouse pancreas revealed by in situ fluorescence imaging
    Dominika M. Wiktor‐Brown, Carrie A. Hendricks, Werner Olipitz, Bevin P. Engelward · 2006 · Proceedings of the National Academy of Sciences
60. Amplification and translocation of 3q26 with overexpression of EVI1 in Fanconi anemia‐derived childhood acute myeloid leukemia with biallelic FANCD1/BRCA2 disruption
    Stefan Meyer, William D. Fergusson, Anthony David Whetton, Flávia Fernandes Moreira-Leite, Stuart De V. Pepper, Crispin J. Miller, Emma Saunders, Daniel J. White, AJ Will, Tim O.B. Eden et al. · 2007 · Genes Chromosomes and Cancer
61. WEE1 inhibition in pancreatic cancer cells is dependent on DNA repair status in a context dependent manner
    Shruti Lal, Mahsa Zarei, Saswati N. Chand, Emanuela Dylgjeri, Nicole Caroline Mambelli-Lisboa, Michael J. Pishvaian, Charles J. Yeo, Jordan Michael Winter, Jonathan Robert Brody · 2016 · Scientific Reports
62. HLA-haploidentical TCRαβ+/CD19+-depleted stem cell transplantation in children and young adults with Fanconi anemia
    Luisa Strocchio, Daria Pagliara, Mattia Algeri, Giuseppina Li Pira, Francesca Rossi, Valentina Bertaina, Giovanna Leone, Rita Maria Pinto, Marco Andreani, Emanuele Agolini et al. · 2021 · Blood Advances
63. A new frontier in Fanconi anemia: From DNA repair to ribosome biogenesis
    Anna Gueiderikh, Frédérique Maczkowiak, Filippo Rosselli · 2021 · Blood Reviews
64. Formation of cyclophosphamide specific DNA adducts in hematological diseases
    L’Aurelle A. Johnson, Bhaskar Malayappan, Natalia Y. Tretyakova, Colin J. Campbell, Margaret L. MacMillan, John E. Wagner, Pamala A. Jacobson · 2011 · Pediatric Blood & Cancer
65. FANCJ Helicase Operates in the Fanconi Anemia DNA Repair Pathway and the Response to Replicational Stress
    Yuliang Wu, Robert M. Brosh · 2009 · Current Molecular Medicine
66. Targeting DNA Repair in Ovarian Cancer Treatment Resistance
    Michelle W. Wong‐Brown, André van der Westhuizen, Nikola A. Bowden · 2020 · Clinical Oncology
67. Chromosomal changes characterize head and neck cancer with poor prognosis
    Verena L. Bauer, Herbert Braselmann, Michael Henke, Dominik Mattern, Axel Karl Walch, Kristian Unger, Michael Baudis, Silke Laßmann, Reinhard Huber, Johannes Wienberg et al. · 2008 · Journal of Molecular Medicine
68. The role of next‐generation sequencing in the investigation of ultrasound‐identified fetal structural anomalies
    Mark David Kilby · 2020 · BJOG An International Journal of Obstetrics & Gynaecology
69. Homologous Recombination in Eukaryotes
    Ravindra Amunugama, Richard A. Fishel · 2012 · Progress in molecular biology and translational science
70. IL-4Rα Expression by Bone Marrow-Derived Cells Is Necessary and Sufficient for Host Protection against Acute Schistosomiasis
    De’Broski R. Herbert, Tatyana Orekov, Charles L. Perkins, Marc E. Rothenberg, Fred D. Finkelman · 2008 · The Journal of Immunology
71. Modification of Ovarian Cancer Risk by BRCA1/2 -Interacting Genes in a Multicenter Cohort of BRCA1/2 Mutation Carriers
    Timothy Richard Rebbeck, Nandita Mitra, Susan M. Domchek, Fei Wan, Shannon Chuai, Tara M. Friebel, Saarene Panossian, Amanda B. Spurdle, Georgia Chenevix‐Trench, kConFab et al. · 2009 · Cancer Research
72. DNA Repair Protein Biomarkers Associated with Time to Recurrence in Triple-Negative Breast Cancer
    Brian Michael Alexander, Kam M. Sprott, D. Allan Farrow, XiaoZhe Wang, Alan D. D’Andrea, Stuart J. Schnitt, Laura C. Collins, David T. Weaver, Judy Ellen Garber · 2010 · Clinical Cancer Research
73. Spectrum ofFANCA mutations in Italian Fanconi anemia patients: Identification of six novel alleles and phenotypic characterization of the S858R variant
    Maria Savino, Adriana Borriello, Maria D’Apolito, Maria Criscuolo, Maria Del Vecchio, Anna Monica Bianco, Michele Di Perna, Rita Calzone, Brúno Nobili, Adriana Zatterale et al. · 2003 · Human Mutation
74. Fanconi Anemia Repair Pathway Dysfunction, a Potential Therapeutic Target in Lung Cancer
    Wenrui Duan, Li Gao, Brittany Aguila, Arjun Kalvala, Gregory A. Otterson, Miguel Angel Villalona-Calero · 2014 · Frontiers in Oncology
75. The impact of FANCD2 deficiency on formaldehyde-induced toxicity in human lymphoblastoid cell lines
    Xuefeng Ren, Zhiying Ji, Cliona M. McHale, Jessica Yuh, Jessica Bersonda, Maycky Tang, Martyn T. Smith, Luoping Zhang · 2012 · Archives of Toxicology
76. CURRENT DIAGNOSIS OF INHERITED BONE MARROW FAILURE SYNDROMES
    Hannah Tamary, Blanche P. Alter · 2007 · Pediatric Hematology and Oncology
77. BRCA1 Contributes to Cell Cycle Arrest and Chemoresistance in Response to the Anticancer Agent Irofulven
    Timothy D. Wiltshire, Jamie Senft, Yutian Wang, Gregory W. Konat, Sharon L. Wenger, Eddie Reed, Weixin Wang · 2007 · Molecular Pharmacology
78. Drug design with Cdc7 kinase: a potential novel cancer therapy target
    Hisao Masai · 2008 · Drug Design Development and Therapy
79. FANCD2 protein is expressed in proliferating cells of human tissues that are cancer‐prone in Fanconi anaemia
    Michael Hölzel, P. J. van Diest, Patrick Bier, Michael Wallisch, Maureen E. Hoatlin, Hans Joenje, Johan P. de Winter · 2003 · The Journal of Pathology
80. Diamond Blackfan Anemia: New Paradigms for a “Not So Pure” Inherited Red Cell Aplasia
    Jeffrey Michael M Lipton · 2006 · Seminars in Hematology
81. Fanconi anemia type C–deficient hematopoietic stem/progenitor cells exhibit aberrant cell cycle control
    Xiaxin Li, Paul Artur Plett, Yanzhu Yang, Ping Hong, Brian W. Freie, Edward F. Srour, Christie M. Orschell, D. Wade Clapp, Laura S. Haneline · 2003 · Blood
82. Identification of multiple nuclear export sequences in Fanconi anemia group A protein that contribute to CRM1-dependent nuclear export
    Miriam Ferrer, José Antonio Rodríguez, Ellen A. Spierings, Johan P. de Winter, Giuseppe Giaccone, Frank A.E. Kruyt · 2005 · Human Molecular Genetics
83. Familial Pancreatic Cancer and the Future of Directed Screening
    Sara Welinsky, Aimee Lee Lucas · 2017 · Gut and Liver
84. A case report and literature review of Fanconi Anemia (FA) diagnosed by genetic testing
    Ponnumony John Solomon, Priya Margaret, Ramya Rajendran, Revathy Ramalingam, Godfred Antony Menezes, Alph S Shirley, Seung Jun Lee, Moon‐Woo Seong, Sung Sup Park, Dodam Seol et al. · 2015 · The Italian Journal of Pediatrics/Italian journal of pediatrics
85. Salivary Gland Cancer inBRCA-Positive Families
    Tim K. Shen, Theodoros Nicholas Teknos, Amanda Ewart Toland, Leigha A. Senter, Rebecca S. Nagy · 2014 · JAMA Otolaryngology–Head & Neck Surgery
86. The Fanconi anemia pathway in replication stress and DNA crosslink repair
    Mathew V. Jones, Tony T. Huang · 2012 · Cellular and Molecular Life Sciences
87. Genetic Predisposition Syndromes and Their Management
    David Euhus, Linda D. Robinson · 2013 · Surgical Clinics of North America
88. The ubiquitin ligase Triad1 inhibits myelopoiesis through UbcH7 and Ubc13 interacting domains
    Jurgen A. F. Marteijn, Laurens T. van der Meer, Judith J. Smit, Sylvie M. Noordermeer, Willemijn M. Wissink, Patrick A.M. Jansen, Herman G.P. Swarts, Richard G. Hibbert, T. de Witte, Titia K. Sixma et al. · 2009 · Leukemia
89. Comprehensive review of genetic factors contributing to head and neck squamous cell carcinoma development in low‐risk, nontraditional patients
    Morgan A. Gingerich, Joshua D. Smith, Nicole Lynn Michmerhuizen, Megan Ludwig, Samantha N. Devenport, Chloe N. Matovina, John Chad Brenner, Steven Bennett Chinn · 2018 · Head & Neck
90. Chemosensitizing tumor cells by targeting the Fanconi anemia pathway with an adenovirus overexpressing dominant-negative FANCA
    Miriam Ferrer, Johan P. de Winter, D C J Mastenbroek, David T. Curiel, Winald R. Gerritsen, Giuseppe Giaccone, Frank A.E. Kruyt · 2004 · Cancer Gene Therapy
91. Inherited bone marrow failure syndromes in 2012
    Hirotoshi Sakaguchi, Koji Nakanishi, Seiji Kojima · 2012 · International Journal of Hematology
92. Zebrafish as a model of human hematologic disorders
    Ebrahim Shafizadeh, Barry H. Paw · 2004 · Current Opinion in Hematology
93. Increased red cell distribution width in Fanconi anemia: a novel marker of stress erythropoiesis
    Rosa Sousa, Cristina Gonçalves, Isabel Couto Guerra, Emília Costa, Ana Fernandes, Maria do Bom Sucesso, Joana Azevedo, Alfredo Rodríguez, Rocío Rius, Carlos Seabra et al. · 2016 · Orphanet Journal of Rare Diseases
94. Genomic amplification of Fanconi anemia complementation group A (FancA) in head and neck squamous cell carcinoma (HNSCC): Cellular mechanisms of radioresistance and clinical relevance
    Julia Heß, Kristian Unger, Michael Orth, Ulrike Schötz, Lars Schüttrumpf, Verena Zangen, I. Gimenez-Aznar, Agata Michna, Ludmila Schneider, Ramona Stamp et al. · 2016 · Cancer Letters
95. Phase 2 Study of Talazoparib in Patients With Homologous Recombination Repair–Deficient Squamous Cell Lung Cancer: Lung-MAP Substudy S1400G
    Taofeek Kunle Owonikoko, Mary Weber Redman, Lauren A. Byers, Fred R. Hirsch, Philip C. Mack, Lawrence Howard Schwartz, Jeffrey D. Bradley, Thomas E. Stinchcombe, Natasha B. Leighl, Tareq Al Baghdadi et al. · 2021 · Clinical Lung Cancer
96. PARP inhibition and synthetic lethality in ovarian cancer
    Ramez Nassef Eskander, Krishnansu S. Tewari · 2014 · Expert Review of Clinical Pharmacology
97. Celastrol induces proteasomal degradation of FANCD 2 to sensitize lung cancer cells to DNA crosslinking agents
    Guizhen Wang, Yongqiang Liu, Xin Cheng, Guang‐Biao Zhou · 2015 · Cancer Science
98. Bilateral adrenal neuroblastoma and nephroblastoma occurring synchronously in a child with Fanconi's anemia and VACTERL syndrome
    Dominique D. Berrebi, Marie‐Noëlle Lebras, N. Belarbi, Jérôme Couturier, Sarah Fattet, Albert Faye, Michel M. Peuchmaur, Pascal P. De Lagausie · 2006 · Journal of Pediatric Surgery
99. Genetic inactivation of the Fanconi anemia gene FANCC identified in the hepatocellular carcinoma cell line HuH-7 confers sensitivity towards DNA-interstrand crosslinking agents
    Andreas Palagyi, Kornelia Neveling, Ursula Plinninger, Andreas Ziesch, Bianca‐Sabrina Targosz, Gerald Denk, Stephanie Ochs, Antonia Rizzani, Daniel Meier, Wolfgang Erwin Thasler et al. · 2010 · Molecular Cancer
100. DNA repair disorders causing malformations
     Barbara F. Hales · 2005 · Current Opinion in Genetics & Development